Results 91 to 100 of about 28,144 (206)

Long‐Term Outcome After Pulsed Field Ablation for Atrial Fibrillation Across an Atrial Septal Defect Closure Device: A 20‐Month Follow‐Up Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Balloon‐assisted transseptal puncture across a large atrial septal defect closure device can permit pulsed‐field ablation in selected patients with complex septal anatomy, achieving durable pulmonary vein isolation and sinus rhythm. A borderline residual left‐to‐right shunt developed post‐procedure but decreased on serial imaging without ...
Ahmed Abdelrazik, Ibrahim Antoun, Ivelin Koev, Mahmoud Eldesouky, Marinos Kantzis, G. Andre Ng   +5 more
wiley   +1 more source

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

, 2017
Yukihiro Koretsune,1 Takanori Ikeda,2 Ken Kozuma,3 Teruyuki Hirano,4 Masahiro Yasaka,5 Makoto Kida,6 Motohiko Chachin,7 Miki Imura7 1National Hospital Organization, Osaka National Hospital, Osaka, 2Department of Cardiovascular Medicine, Toho University ...
Kozuma K, Hirano T, Imura M, Yasaka M, Koretsune Y, Kida M, Chachin M, Ikeda T   +7 more
core  

Patient Self‐Reported Global Satisfaction With Rivaroxaban in Patients With Atrial Fibrillation: A Comparison Between Oral Anticoagulation‐Naïve Versus Oral Anticoagulation‐Experienced Patients

Clinical Cardiology, Volume 49, Issue 9, September 2026.
Comparisons of the levels of and time trends in patient global satisfaction with rivaroxaban in OAC‐naïve and OAC‐experienced AF patients using a 5‐point scale. Our results suggest that OAC‐naïve patients need additional support, reassurance and more intense clinical follow‐up, particularly in the first 6 months after initiation of DOAC therapy ...
Bogdan G. Markovic, Miroslav Mihajlovic, Aleksandar Kocijancic, Jelena Simic, Milan Marinkovic, Vladan Kovacevic, Milica Ivanisevic, Nikola Isailovic, Nebojsa Mujovic, Belma Pojskic, Tatjana Potpara, the GUARDIAN Investigators   +11 more
wiley   +1 more source

Safety of anticoagulation with apixaban following acute traumatic brain injury: A case series

World Neurosurgery: X
Background: The rise in traumatic brain injuries (TBI) among geriatric patients, often using direct oral anticoagulants (DOACs), underscores the urgency to explore safe resumption of these medications post-injury.
Abhishek R. Mogili, Rodnell Busigó-Torres, Pemla Jagtiani, Bashar Zaidat, Jueria Rahman, Thomas Fetherston, Salazar A. Jones, Laura Salgado-Lopez, Zachary L. Hickman   +8 more
doaj   +1 more source

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

, 2015
Molly W Mandernach,1 Rebecca J Beyth,1,2 Anita Rajasekhar11Division of Hematology and Oncology, College of Medicine, University of Florida, Gainesville, FL, USA; 2North Florida/South Georgia Veterans Health System (NF/SGVHS), Geriatric Research ...
Beyth RJ, Mandernach MW, Rajasekhar A
core  

Apixaban plasma level and anti-FXa activity in control and apixaban with amiodarone groups.

Apixaban plasma level and anti-FXa activity in control and apixaban with amiodarone groups.
Weerayuth Saelim (17817282), Wichai Santimaleeworagun (8679282), Pornwalai Boonmuang (17817273), Sutee Limcharoen (17817270), Manat Pongchaidecha (17817276), Sarawuth Limprasert (8931053), Juthathip Suphanklang (17817279), Piyarat Pimsi (17817285)   +7 more
core   +1 more source

APIXABAN – FROM RECOMMENDATIONS TO EVERYDAY PRACTICE [PDF]

, 2016
The articles deals with the analysis of clinical situations in patients with atrial fibrillations in the aspect of choice of the anticoagulant therapy with apixaban use in relation with the recent (2015) recommendations of the European Heart Rhythm ...
N. N. DENISOVA, A. Y. BLEDNOVA, L. N. ELISEEVA, E. L. SHUKHARDINA   +3 more
core   +1 more source

Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 762-773, September 2026.
Plasma 4β‐hydroxycholesterol (4β‐OHC) normalized for the levels of its parent cholesterol (4β‐OHC/C) is an endogenous biomarker for hepatic CYP3A4. This study evaluated CYP3A4 activity longitudinally in individuals while their obesity status was changing. 4β‐OHC/C was measured pre‐surgery (n = 54) and 2 years after Roux‐en‐Y gastric bypass (n = 30) and
Nihan Izat, Haribhau Kangne, Rasmus Jansson‐Löfmark, Jens K. Hertel, Amin Rostami‐Hodjegan, Ida Robertsen, Aleksandra Galetin   +6 more
wiley   +1 more source

Practical management of patients on apixaban: a consensus guide [PDF]

, 2013
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence over 10% in older patients. AF is the leading preventable cause of ischaemic stroke, and strokes due to AF have a higher mortality and morbidity.
Geoffrey Donnan, Donnan, G, Simon McRae, Christopher Ward, McRae, S, Greg Conner, Alexander Gallus, Ward, C, Conner, G, Gallus, A   +9 more
core   +1 more source

Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant‐Based Therapies: A Narrative Review

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, encompassing coronary artery disease, hypertension, heart failure, and cerebrovascular disorders. The global burden of CVD continues to rise, driven by complex interactions among endothelial dysfunction, oxidative stress, inflammation,
Nawfal Hasan Siam, Umme Halima Mithila, Sadia Alam Tisha, Hridoy Saha, Ayesha Binte Mahbub, Farhan Nizam, Johirul Islam, Noushin Tabasumma, Md. Mazharul Islam Chowdhury   +8 more
wiley   +1 more source